Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

A clinical study of MK-3508 in healthy people (MK-3508-006) Ended

2024-516619-26-00 Respiratory syncytial virus infection 3 2024-11-04
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection Ended

2023-509684-24-00 Hepatitis B 7 2024-10-31
Open-label, randomized, two-treatment, two-period, two-sequence, cross-over, single dose, bioequivalence study comparing ISOPRINOSINE® FORTE… Ended

2024-514146-37-00 not applicable (submitted trial is a bioequivalence stu 2 2024-10-24
A clinical study of the V540A vaccine in healthy adults (V540A-001) Ended

2024-515785-14-00 Human Papilloma virus 1 2024-10-22
An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Val… Ended

2024-516184-87-00 not applicable (submitted trial is a bioavailability st 2 2024-10-18
Phase 2a, single center, randomized, double-blind, study to evaluate the immunogenicity and safety of one single administration of OVX836 in… Ended

2024-516267-83-00 Influenza 4 2024-10-15
A Study to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Influenza Vaccine Compared with a Licensed Influenza … Ended

2024-516240-26-00 Influenza 5 2024-10-11
Immunogenicity of licensed MF59 adjuvanted Influenza and SARS-CoV-2 vaccine combinations for Older Adults (ISOLDA) Ended

2024-514798-23-00 COVID-19 and flu 4 2024-10-02
A clinical trial to determine if AIC263029 is safe when dosed only once or several times, and to investigate how it moves within the human b… Ended

2023-510074-13-00 BKV-associated nephropathy 1 2024-10-02
Study on PhArmacokiNetics of first liNe Antiretrovirals in healthy Breastfeeding volunteers or women living with HIV and already on antiretr… Ended

2023-510232-36-00 healthy breastfeeding women 3 2024-10-01
A Phase I Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 against Crimean Congo Hemorrhagic Fever (CCHF-NP-1) Ended

2023-508556-18-00 Crimean Congo Hemorrhagic Fever 1 2024-09-25
Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial Ended

2024-513558-30-00 Influenza 6 2024-09-25
Cytomegalovirus Prophylaxis with Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study Ended

2024-517354-98-00 CMV infection in heart transplant recipients 4 2024-09-17
YF_PROTECT: Prophylactic treatment with sofosbuvir for Yellow Fever Ended

2024-510949-34-00 Healthy volunteers 6 2024-09-11
Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers Ended

2023-505762-29-00 Virus diseases 5 2024-08-09
European randomised clinical trial on mPOX Infection (EPOXI) Ended

2022-501979-10-00 Monkeypox 6 2024-08-08
A study on the immune response, safety and the occurrence of RSV-associated respiratory tract illness after administration of RSV OA vaccine… Ended

2023-509455-13-00 Respiratory Syncytial Virus Infections 11 2024-08-05
HepBTer: From fungus to virus, a phase 2a clinical trial investigating the safety and efficacy of terbinafine in chronic hepatitis B patient… Ended

2024-514888-25-00 Chronic hepatitis B 4 2024-07-25
Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome… Ended

2024-511628-16-00 Post Covid Syndrome (PCS) 4 2024-07-18
Optimizing reversal of HIV latency with combination therapy (pyrimethamine, lenalidomide, panobinostat) Ended

2024-511192-15-00 HIV-1 4 2024-07-07
First-in-human Phase 1 Study to Assess the Safety, Tolerability, and Immunogenicity of the Adjuvanted Universal Influenza Vaccine “fH1/DSP-0… Ended

2023-504378-39-00 Influenza 1 2024-06-26
MK-4646 Single Ascending Dose Study and DDI in Healthy Participants Ended

2024-510899-20-00 HIV infection 1 2024-06-19
A Phase I, randomized, double-blind, multi-centre, placebo-controlled, dose-escalation study to evaluate the safety, reactogenicity and immu… Ended

2024-511194-29-00 Yellow fever 1 2024-06-16
A study on the immune response and safety of a vaccine against respiratory syncytial virus (RSV) when given alone and together with a vaccin… Ended

2023-510196-59-00 Respiratory Syncytial Virus Infections 5 2024-06-15